Private companies are Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) biggest owners and were hit after market cap dropped HK$559m

Simply Wall St.11-16

Key Insights Significant control over Sihuan Pharmaceutical Holdings Group by private companies implies that the general public has more power to influence management and governance-related decisions...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2483565553?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","is_english":true,"pubTime":"2024-11-16 06:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2483565553","market":"us","top_or_hot":-1,"title":"Private companies are Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) biggest owners and were hit after market cap dropped HK$559m","media":"Simply Wall St.","content":"<div>\n<p>Key Insights  Significant control over Sihuan Pharmaceutical Holdings Group by private companies implies that the general public has more power to influence management and governance-related decisions...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/private-companies-are-sihuan-pharmaceutical-holdings-group-l\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Private companies are Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) biggest owners and were hit after market cap dropped HK$559m</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPrivate companies are Sihuan Pharmaceutical Holdings Group Ltd.'s (HKG:460) biggest owners and were hit after market cap dropped HK$559m\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-16 06:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/private-companies-are-sihuan-pharmaceutical-holdings-group-l><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Insights  Significant control over Sihuan Pharmaceutical Holdings Group by private companies implies that the general public has more power to influence management and governance-related decisions...</p>\n\n<a href=\"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/private-companies-are-sihuan-pharmaceutical-holdings-group-l\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1593","symbol_name":"医美概念股","start_time":0,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-460/sihuan-pharmaceutical-holdings-group-shares/news/private-companies-are-sihuan-pharmaceutical-holdings-group-l","article_id":"2483565553","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2483565553","pubTimestamp":1731710720,"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Key Insights Significant control over Sihuan Pharmaceutical Holdings Group by private companies implies that the...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1593":"医美概念股","BK1600":"工业大麻","00460":"四环医药","BK1515":"抗疫概念","BK1191":"制药"},"translate_title":"私营公司是四环医药控股集团有限公司（HKG：460）的最大所有者，在市值下跌5.59亿港元后受到打击","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00460":1},"content_text":"Key Insights  Significant control over Sihuan Pharmaceutical Holdings Group by private companies implies that the general public has more power to influence management and governance-related decisions   A total of 4 investors have a majority stake in the company with 52% ownership   Using data from company's past performance alongside ownership research, one can better assess the future performance of a company   If you want to know who really controls Sihuan Pharmaceutical Holdings Group Ltd. (HKG:460), then you'll have to look at the makeup of its share registry.  With 50% stake, private companies possess the maximum shares in the company.   That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).  And last week, private companies endured the biggest losses as the stock fell by 8.2%.     Let's delve deeper into each type of owner of Sihuan Pharmaceutical Holdings Group, beginning with the chart below.  See our latest analysis for Sihuan Pharmaceutical Holdings Group SEHK:460 Ownership Breakdown November 15th 2024 What Does The Institutional Ownership Tell Us About Sihuan Pharmaceutical Holdings Group? Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.   Institutions have a very small stake in Sihuan Pharmaceutical Holdings Group. That indicates that the company is on the radar of some funds, but it isn't particularly popular with professional investors at the moment.  If the business gets stronger from here, we could see a situation where more institutions are keen to buy.  When multiple institutional investors want to buy shares, we often see a rising share price. The past revenue trajectory (shown below) can be an indication of future growth, but there are no guarantees. SEHK:460 Earnings and Revenue Growth November 15th 2024  We note that hedge funds don't have a meaningful investment in Sihuan Pharmaceutical Holdings Group.      Proper Process International Limited is currently the company's largest shareholder with 31% of shares outstanding.        Meanwhile, the second and third largest shareholders, hold 12% and 5.3%, of the shares outstanding, respectively.     Fengsheng Che, who is the third-largest shareholder, also happens to hold the title of Chairman of the Board.      On looking further, we found that 52% of the shares are owned by the top 4 shareholders. In other words, these shareholders have a meaningful say in the decisions of the company.     While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing.   Our information suggests that there isn't any analyst coverage of the stock, so it is probably little known.  Insider Ownership Of Sihuan Pharmaceutical Holdings Group The definition of company insiders can be subjective and does vary between jurisdictions. Our data reflects individual insiders, capturing board members at the very least.  The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.  I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.   We can report that insiders do own shares in Sihuan Pharmaceutical Holdings Group Ltd..   In their own names, insiders own HK$475m worth of stock in the HK$6.2b company.   It is good to see some investment by insiders, but it might be worth checking if those insiders have been buying.   General Public Ownership The general public, who are usually individual investors, hold a 38% stake in Sihuan Pharmaceutical Holdings Group.   While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.  Private Company Ownership Our data indicates that Private Companies hold 50%, of the company's shares.   It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.   Next Steps: I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too.    Be aware that  Sihuan Pharmaceutical Holdings Group is showing  1 warning sign in our investment analysis , you should know about...      If you would prefer check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, backed by strong financial data.  NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"Shareholding Changes","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2483565553"}